Letter: lipid‐lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B—more evidence is needed. Authors’ reply

Linked ContentThis article is linked to Huang et al and Shaheen et al papers. To view these articles visit https://doi.org/10.1111/apt.14266 and https://doi.org/10.1111/apt.14218.

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2017-10, Vol.46 (8), p.770-771
Main Authors: Shaheen, A. A., Al‐Mattooq, M., Yazdanfar, S., Burak, K. W., Swain, M. G., Congly, S. E., Borman, M. A., Lee, S. S., Myers, R. P., Coffin, C. S.
Format: Article
Language:English
Subjects:
Hepatitis
Hepatitis B
Tenofovir
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Linked ContentThis article is linked to Huang et al and Shaheen et al papers. To view these articles visit https://doi.org/10.1111/apt.14266 and https://doi.org/10.1111/apt.14218.
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.14282